TVGN - Tevogen Bio Holdings Inc.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 0.4171

Open

$ 0.43

Bid

$ 0.42 x 13

Ask

$ 0.42 x 700

Day's Range

$ 0.42 - $ 0.44

52 Week Range

$ 0.42 - $ 1.92

Volume

429,321

Average Volume

Market Cap

82.87M

Beta (5Y Monthly)

$ 0.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-14-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	04-02-2025	12-31-2024	10-K
5	11-19-2024	09-30-2024	10-Q
6	08-14-2024	06-30-2024	10-Q
7	05-28-2024	03-31-2024	10-Q
8	04-27-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-21-2023	06-30-2023	10-Q
11	05-22-2023	03-31-2023	10-Q
12	04-17-2023	12-31-2022	10-K
13	11-14-2022	09-30-2022	10-Q
14	08-15-2022	06-30-2022	10-Q
15	05-17-2022	03-31-2022	10-Q
16	04-01-2022	12-31-2021	10-K
17	12-17-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Tevogen Expands COVID-19 T Cell Therapy Re...
11/05/2025 20:22:53

This milestone expands patient eligibility through multi-HLA targetingBuilds on completed TVGN 489 trial demonstrating 100% vir...

Tevogen Clarifies GAAP-Reported Deficit, P...
11/03/2025 19:55:38

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today issued a statement to provide clarity r...

Tevogen Intends To Collaborate With Govern...
10/15/2025 19:52:31

Company intends to collaborate with government initiatives, Long COVID patient organizations, and major healthcare providers to...

Tevogen Bio Announces Progress On Its Pred...
09/25/2025 12:37:10

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ: TVGN), today announced significant progress in the ...

Tevogen Highlights Potential Of Precision ...
09/23/2025 12:44:31

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today highlights emerging scientific evidence...

Tevogen Bio Estimates TVGN 116 Cumulative ...
09/09/2025 19:20:11

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ: TVGN), today shared asset value and potential forec...

Tevogen Values TVGN-489 T Cell Therapy For...
09/08/2025 13:32:47

Tevogen Projects $3.5B Revenue For EBV-Tar...
09/04/2025 19:54:22

The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone.Covering five rare...

D. Boral Capital Maintains Buy on Tevogen ...
09/04/2025 11:11:22

D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy and maintains $10 price target.

Tevogen Highlights Clinical Data For TVGN ...
09/03/2025 20:17:06

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today highlighted the continuing need for SAR...

Tevogen Reports 24% Rise In Institutional ...
08/25/2025 19:13:18

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today announced an update on institutional ow...

Tevogen Bio Secures Up To $50M In Financin...
08/19/2025 19:45:21

Includes $36 million line of credit and potential $14 million private placementWARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- ...

D. Boral Capital Maintains Buy on Tevogen ...
08/18/2025 11:33:09

D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy and maintains $10 price target.

Tevogen Bio Highlights Undervalued Intangi...
08/14/2025 19:56:51

Tevogen Bio Holdings Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), today issued the following statement from...

UPDATE: Tevogen Bio Forecasts $1B Launch-Y...
08/11/2025 17:30:48

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2.Forecast adds to Tevogen Bio's Oncology therapeu...

Tevogen Bio Announces $1B Revenue Forecast...
08/11/2025 16:01:17

Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy ...

Tevogen Receives $1M To Advance Tevogen.AI
08/07/2025 13:03:47

Tevogen Reports Institutional Ownership Ju...
08/06/2025 19:59:58

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today announced an update on institutional ow...

D. Boral Capital Maintains Buy on Tevogen ...
08/06/2025 13:10:16

D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy and maintains $10 price target.

Tevogen Bio Holdings Shares Resume Trade
08/05/2025 18:39:19